U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.36%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.32%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.11%)
     
  • BTC-USD

    13,299.08
    +185.54 (+1.41%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Teladoc (TDOC) Gains As Market Dips: What You Should Know

Zacks Equity Research
·2 mins read

Teladoc (TDOC) closed the most recent trading day at $217.34, moving +1.05% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.48%. Elsewhere, the Dow lost 0.48%, while the tech-heavy Nasdaq lost 0.29%.

Heading into today, shares of the telehealth services provider had lost 0.28% over the past month, outpacing the Medical sector's loss of 1.66% and the S&P 500's loss of 4.3% in that time.

Wall Street will be looking for positivity from TDOC as it approaches its next earnings report date. In that report, analysts expect TDOC to post earnings of -$0.33 per share. This would mark year-over-year growth of 15.38%. Meanwhile, our latest consensus estimate is calling for revenue of $281.34 million, up 103.91% from the prior-year quarter.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$1.40 per share and revenue of $990.71 million, which would represent changes of -1.45% and +79.05%, respectively, from the prior year.

It is also important to note the recent changes to analyst estimates for TDOC. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.72% higher. TDOC is currently a Zacks Rank #3 (Hold).

The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 171, which puts it in the bottom 33% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.